It has been proven in clinical trials that a dose of semaglutide taken once per week leads to significant reductions both in bodyweight over 12 weeks as well as long term effects such as lower levels of insulin resistance and improvements on cardiometabolic markers like glycated hemoglobin AICc, triglycerides and C reactive protein concentrations.
As a result, those suffering from obesity related conditions may benefit significantly from its use due to melting away fat faster than with traditional methods alone.
In a study published by the New England Journal of Medicine, semaglutide was found to reduce BMI on average 5% when compared with placebo after 68 weeks. Furthermore, this medication can also cause one’s waist circumference and Hip Circumference to decrease significantly more than what would typically occur from dieting alone or other medications commonly used for weight-loss purposes.